Breaking News - The Fly

Open Search

PHGE

BiomX

$

()

BiomX appoints Blum to board of directors

PHGE

4/18/2024 - 08:06am

BiomX announces compliance with NYSE guidelines on audit opinion disclosure

PHGE

4/4/2024 - 07:53am

BiomX enters merger agreement with Adaptive Phage Therapeutics

PHGE

3/6/2024 - 07:35am

BiomX receives orphan drug designation for BX004 in chronic pulmonary infection

PHGE

1/4/2024 - 08:11am

BiomX treatment of chronic pulmonary infection granted FDA orphan status

PHGE

12/27/2023 - 13:06pm

BiomX files $150M mixed securities shelf

PHGE

12/7/2023 - 17:05pm

BiomX announces results from Part 2 of the Phase 1b/2a trial of BX004

PHGE

11/29/2023 - 06:33am

BiomX appoints Edward Williams to board of directors

PHGE

10/18/2023 - 08:17am

BiomX management to meet with Oppenheimer

PHGE

10/5/2023 - 04:55am

BiomX management to meet with Oppenheimer

PHGE

10/4/2023 - 07:18am

BiomX completes patient dosing in Part 2 of Phase 1b/2a trial evaluating BX004

PHGE

10/4/2023 - 06:37am

BiomX files to sell 31.78M shares of common stock for holders

PHGE

6/2/2023 - 16:03pm

BiomX price target lowered to $7 from $10 at H.C. Wainwright

PHGE

5/15/2023 - 10:47am

BiomX appoints Jason Marks, Michael Dambach to board of directors

PHGE , AMRN , BIIB

5/12/2023 - 08:24am